Anand Viswanathan1, Eric A Macklin, Rebecca Betensky, Bradley Hyman, Eric E Smith, Deborah Blacker. 1. Departments of *Neurology ‡Psychiatry †Hemorrhagic Stroke Research Program §Biostatistics Center ¶Massachusetts Alzheimer Disease Research Center (ADRC), Massachusetts General Hospital and Harvard Medical School, Boston, MA ∥Departments of Biostatistics **Epidemiology, Harvard School of Public Health, Boston, MA #Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.
Abstract
OBJECTIVE: Vascular risk factors in mid-life predict late life cognitive decline in previously normal populations. We sought to investigate the contribution of vascular risk factors in late life to cognitive decline in a cohort of normal elderly individuals. METHODS: Cognitively normal subjects were identified from the longitudinal cohort of participants in the National Alzheimer Coordinating Center (NACC) database (n=2975). The association between a composite score of vascular risk factors (based on the Framingham Stroke Risk Profile) and cognitive function was tested at baseline visit and estimated in longitudinal analyses using linear mixed-effects models. RESULTS: Total vascular risk factor burden was associated with worse cognitive performance at baseline and faster decline longitudinally in univariate analyses but only with worse WAIS digit symbol performance in cross-sectional (estimate=-0.266 units/1 unit of Framingham Stroke Risk Profile Score; 95% confidence interval, -0.380 to -0.153; P<0.001) and longitudinal (estimate=-0.034 units/1 unit of Framingham Stroke Risk Profile Score/year; 95% confidence interval, -0.055 to -0.012; P=0.002) analyses after adjusting for age, education, and APOE genotype. Individuals with history of stroke performed significantly worse on the trails B, category fluency, and Boston naming tests in cross-sectional analyses and in delayed logical memory and digit span backwards in longitudinal analyses. CONCLUSIONS: Although the modified Framingham Stroke Risk Profile in late-life predicts rate of decline on selective neurocognitive measures in previously normal elderly individuals, age appears to be the strongest risk factor for cognitive impairment in this population. History of stroke independently influences rate of cognitive decline in these individuals.
OBJECTIVE: Vascular risk factors in mid-life predict late life cognitive decline in previously normal populations. We sought to investigate the contribution of vascular risk factors in late life to cognitive decline in a cohort of normal elderly individuals. METHODS: Cognitively normal subjects were identified from the longitudinal cohort of participants in the National Alzheimer Coordinating Center (NACC) database (n=2975). The association between a composite score of vascular risk factors (based on the Framingham Stroke Risk Profile) and cognitive function was tested at baseline visit and estimated in longitudinal analyses using linear mixed-effects models. RESULTS: Total vascular risk factor burden was associated with worse cognitive performance at baseline and faster decline longitudinally in univariate analyses but only with worse WAIS digit symbol performance in cross-sectional (estimate=-0.266 units/1 unit of Framingham Stroke Risk Profile Score; 95% confidence interval, -0.380 to -0.153; P<0.001) and longitudinal (estimate=-0.034 units/1 unit of Framingham Stroke Risk Profile Score/year; 95% confidence interval, -0.055 to -0.012; P=0.002) analyses after adjusting for age, education, and APOE genotype. Individuals with history of stroke performed significantly worse on the trails B, category fluency, and Boston naming tests in cross-sectional analyses and in delayed logical memory and digit span backwards in longitudinal analyses. CONCLUSIONS: Although the modified Framingham Stroke Risk Profile in late-life predicts rate of decline on selective neurocognitive measures in previously normal elderly individuals, age appears to be the strongest risk factor for cognitive impairment in this population. History of stroke independently influences rate of cognitive decline in these individuals.
Authors: Yael D Reijmer; Panagiotis Fotiadis; Sergi Martinez-Ramirez; David H Salat; Aaron Schultz; Ashkan Shoamanesh; Alison M Ayres; Anastasia Vashkevich; Diana Rosas; Kristin Schwab; Alexander Leemans; Geert-Jan Biessels; Jonathan Rosand; Keith A Johnson; Anand Viswanathan; M Edip Gurol; Steven M Greenberg Journal: Brain Date: 2014-11-02 Impact factor: 13.501
Authors: M Kivipelto; E L Helkala; M P Laakso; T Hänninen; M Hallikainen; K Alhainen; H Soininen; J Tuomilehto; A Nissinen Journal: BMJ Date: 2001-06-16
Authors: Marco Duering; Benno Gesierich; Stephan Seiler; Lukas Pirpamer; Mariya Gonik; Edith Hofer; Eric Jouvent; Edouard Duchesnay; Hugues Chabriat; Stefan Ropele; Reinhold Schmidt; Martin Dichgans Journal: Neurology Date: 2014-05-02 Impact factor: 9.910
Authors: Beatriz L Rodriguez; Ralph D'Agostino; Robert D Abbott; Abraham Kagan; Cecil M Burchfiel; Katsuhiko Yano; G Webster Ross; Halit Silbershatz; Millicent W Higgins; Jordan Popper; Philip A Wolf; J David Curb Journal: Stroke Date: 2002-01 Impact factor: 7.914
Authors: Merrill F Elias; Lisa M Sullivan; Ralph B D'Agostino; Penelope K Elias; Alexa Beiser; Rhoda Au; Sudha Seshadri; Charles DeCarli; Philip A Wolf Journal: Stroke Date: 2004-01-15 Impact factor: 7.914
Authors: Isabelle Pelcher; Christian Puzo; Yorghos Tripodis; Hugo J Aparicio; Eric G Steinberg; Alyssa Phelps; Brett Martin; Joseph N Palmisano; Elizabeth Vassey; Cutter Lindbergh; Ann C McKee; Thor D Stein; Ronald J Killiany; Rhoda Au; Neil W Kowall; Robert A Stern; Jesse Mez; Michael L Alosco Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Elizabeth E Devore; Tamara G Fong; Edward R Marcantonio; Eva M Schmitt; Thomas G Travison; Richard N Jones; Sharon K Inouye Journal: J Gerontol A Biol Sci Med Sci Date: 2017-11-09 Impact factor: 6.053